Medical devices

Biocompatibility and safety analyses for medical devices according to GLP and ISO 10993

The contact of medical devices with the human body requires scientific proof of the device's safety. The biocompatibility assessment includes the analysis of risks such as irritation and sensitization, systemic toxicity, tissue damage, genetic damage (mutagenicity), and other adverse effects.

The ISO 10993 series of standards forms the international framework for the biological evaluation of medical devices; compliance with GLP (Good Laboratory Practice) ensures the reliability and traceability of the investigations.

Medical devices come into direct or indirect contact with the human body for diagnostic, therapeutic, monitoring, or support purposes. The duration and type of contact (surface product, external communicating device, implant) determine the biological risk profile of the product.

The ISO 10993 series of standards defines the biological evaluations to be carried out depending on the type of product and the duration of contact. GLP-compliant working methods mean that the organization of the testing facility, quality assurance, standard operating procedures (SOPs), raw data recording, and reporting comply with OECD GLP principles. ISO 17025 accreditation, on the other hand, certifies the competence of laboratories in testing and calibration at an international level. Together, these two elements underpin the reliability of biocompatibility data from both a scientific and regulatory perspective.

1. Biocompatibility analyses

Biocompatibility tests assess whether a medical device is safe when it comes into contact with the human body. These tests analyze the following risks:

  • Irritation and sensitization
  • Systemic toxicity
  • Tissue damage
  • Genetic damage (mutagenicity)
  • Other adverse effects

ISO 10993-1 recommends the preparation of a biological evaluation plan according to the type and duration of the product's contact.

2. GLP-compliant in vivo laboratories

In vivo studies may be required in biocompatibility assessment, particularly regarding systemic toxicity, implantation, and certain genotoxicity endpoints. In compliance with ethical standards:

  • Controlled environment systems ensure conditions that correspond to the physiological needs of the animals.

Pressure-controlled closed chambers and similar systems are used to keep environmental variables under control.

The studies are carried out using systems that prioritize animal welfare, observing the 3R principles (Replacement, Reduction, Refinement).

In GLP-compliant in vivo laboratories, test substance preparation, dose administration, observations, clinical pathology, histopathology, and data collection must be carried out in accordance with SOPs. Approval by animal ethics committees, staff qualification, and facility accreditation are also inseparable parts of this process.

3. ISO 17025-accredited in vitro laboratories

In vitro tests represent an important component of the biocompatibility assessment and contribute to reducing the need for animal testing. In ISO 17025-accredited in vitro laboratories:

  • Modern technical equipment and a specialized team carry out detailed analyses.
  • Alternative test methods are used, such as cytotoxicity tests (ISO 10993-5), in vitro irritation tests (OECD TG 439), and genotoxicity tests (OECD TG 471, 487).
  • Cell culture conditions, controls, data acceptance criteria, and reporting are carried out with traceability within the scope of ISO 17025.

ISO 17025 accreditation underpins the technical competence of the laboratory and the international acceptance of the results. Combined with GLP compliance, the scientific and regulatory reliability of the in vitro data is strengthened.

4. Chemical characterization (ISO 10993-18)

Chemical characterization serves to evaluate the chemical risks to which a medical device may be exposed during its use. In this context, the following are examined:

  • Compatibility with blood and skin
  • Material components
  • Leakage and release analyses
  • Interactions with cleaning chemicals.

ISO 10993-18 covers the determination of the chemical composition of the product as well as the evaluation of production residues, degradation products, and extractables/leachables.

For all details and inquiries, please feel free to contact us.